newsfilter
← Latest News
GlobeNewswire·

GeoVax to Present at the Noble Capital Markets Twentieth Annual Emerging Growth Equity Conference

ATLANTA, Nov. 26, 2024 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (NASDAQ:GOVX), a biotechnology company specializing in developing human vaccines and cancer immunotherapies, today announced that its Chairman & CEO,